To examine the corresponding impact of ACT+MS-275 treatment on Treg abundance, we stained frozen tumor sections with anti-Foxp3 antibody for immunohistochemistry and immunofluorescence imaging. The gene discussed is FOXP3; the disease is neoplasm.